European Medicines Agency (EMA)
EMA/76828/2018

Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing.

No new patients should start treatment for the time being

Télécharger l'article (en Anglais)

Lien source :
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/02/news_detail_002902.jsp&mid=WC0b01ac058004d5c1

Partager cet article

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedIn

don fsf cngof5